<p>Reliant Investment Management LLC 在最近向证券交易委员会（SEC）提交的 13F 文件中披露，其在赛默飞世尔（Thermo Fisher Scientific Inc.，NYSE:TMO - 免费报告）的股份在第二季度增加了 7.0%。该公司在本季度额外购买了 860 股后，持有该医疗研究公司 13,196 股股票。赛默飞世尔约占 Reliant Investment Management LLC 投资组合的 2.3%，成为其第 25 大持仓。根据其最近向证券交易委员会（SEC）提交的文件，Reliant Investment Management LLC 在赛默飞世尔的持股价值为 5,350,000 美元。</p>
<ul>
<li>现金流关注：赛默飞世尔、能源转移和网易</li>
</ul>
<p>其他几家对冲基金和机构投资者也调整了对该股票的持有。Revolve Wealth Partners LLC 在第四季度将其在赛默飞世尔的股份增加了 4.2%。Revolve Wealth Partners LLC 目前持有 491 股该医疗研究公司的股票，价值 255,000 美元，此前在该期间内额外购买了 20 股。Lafayette Investments Inc. 在第二季度将其在赛默飞世尔的股份增加了 2.4%。Lafayette Investments Inc. 目前持有 927 股该医疗研究公司的股票，价值 376,000 美元，此前在该期间内额外购买了 22 股。Root Financial Partners LLC 在第一季度将其在赛默飞世尔的股份增加了 5.0%。Root Financial Partners LLC 目前持有 506 股该医疗研究公司的股票，价值 252,000 美元，此前在该期间内额外购买了 24 股。Rossmore Private Capital 在第一季度将其在赛默飞世尔的股份增加了 0.5%。Rossmore Private Capital 目前持有 4,652 股该医疗研究公司的股票，价值 2,315,000 美元，此前在该期间内额外购买了 24 股。最后，FARMERS &amp; MERCHANTS TRUST Co OF LONG BEACH 在第二季度将其在赛默飞世尔的股份增加了 3.1%。FARMERS &amp; MERCHANTS TRUST Co OF LONG BEACH 目前持有 803 股该医疗研究公司的股票，价值 326,000 美元，此前在该期间内额外购买了 24 股。机构投资者持有该公司 89.23% 的股票。</p>
<h2>赛默飞世尔股票上涨 1.9%</h2>
<p>NYSE:TMO 周四开盘价为 568.42 美元。赛默飞世尔的 1 年最低价为 385.46 美元，1 年最高价为 610.97 美元。该公司的流动比率为 1.93，速动比率为 1.50，债务股本比率为 0.65。该股票的市值为 2146.4 亿美元，市盈率为 32.88，PEG 比率为 3.22，贝塔值为 0.77。该股票的 50 日移动平均价格为 500.65 美元，200 日移动平均价格为 451.30 美元。</p>
<ul>
<li>安捷伦科技受益于对持久化学品的打击</li>
</ul>
<p>赛默飞世尔（NYSE:TMO - 获取免费报告）最近于 10 月 22 日发布了季度财报。该医疗研究公司报告本季度每股收益为 5.79 美元，超出分析师一致预期的 5.50 美元，超出幅度为 0.29 美元。该公司本季度的收入为 111.2 亿美元，而分析师预期为 109 亿美元。赛默飞世尔的股本回报率为 16.82%，净利润率为 15.24%。与去年同期相比，该公司的季度收入增长了 4.9%。在去年同期，该公司每股收益为 5.28 美元。赛默飞世尔已将其 2025 财年的指引设定为每股收益 22.600-22.860 美元。整体来看，股票分析师预计赛默飞世尔在当前年度将发布每股收益 23.28 美元。</p>
<h2>赛默飞世尔的内部买卖</h2>
<p>在其他赛默飞世尔的新闻中，执行副总裁 Gianluca Pettiti 于 7 月 25 日星期五出售了 400 股赛默飞世尔的股票。该股票以平均价格 479.98 美元出售，总价值为 191,992.00 美元。交易完成后，该执行副总裁直接持有 22,367 股公司的股票，价值 10,735,712.66 美元。此次交易使其持股减少了 1.76%。该出售在向证券交易委员会的法律文件中披露，相关信息可在 SEC 网站上找到。此外，首席会计官 Joseph R. Holmes 于 8 月 29 日星期五出售了 385 股公司的股票。该股票以平均价格 492.63 美元出售，总价值为 189,662.55 美元。出售后，首席会计官持有 2,319 股公司的股票，价值 1,142,408.97 美元。此次交易使其持股减少了 14.24%。该出售的披露信息可在此处找到。在过去 90 天内，内部人士已出售价值 14,182,963 美元的 30,066 股公司股票。公司内部人士持有公司股票的 0.33%。</p>
<h2>分析师设定新的价格目标</h2>
<ul>
<li>S&amp;P 500 中增长最快的 4 大股息：买入、卖出还是持有？</li>
</ul>
<p>多家券商对 Thermo Fisher Scientific 发布了报告。摩根大通将 Thermo Fisher Scientific 的目标价从 600.00 美元上调至 650.00 美元，并在 10 月 9 日的研究报告中给予该公司 “增持” 评级。加拿大皇家银行在 9 月 2 日的研究报告中设定了 Thermo Fisher Scientific 的目标价为 561.00 美元，并给予该公司 “跑赢大盘” 评级。罗伯特·W·贝尔德将 Thermo Fisher Scientific 的目标价从 553.00 美元上调至 567.00 美元，并在 7 月 24 日的研究报告中给予该公司 “跑赢大盘” 评级。巴克莱将 Thermo Fisher Scientific 的目标价从 550.00 美元上调至 585.00 美元，并在 10 月 2 日的研究报告中给予该公司 “增持” 评级。最后，雷蒙德·詹姆斯金融在 7 月 24 日的研究报告中重申了 “跑赢大盘” 评级，并将 Thermo Fisher Scientific 的目标价设定为 535.00 美元（之前为 525.00 美元）。十六位研究分析师对该股票给予了买入评级，五位分析师对该公司的股票给予了持有评级。根据 MarketBeat.com 的数据，该股票目前的共识评级为 “适度买入”，共识目标价为 582.16 美元。</p>
<p><strong>获取我们关于 Thermo Fisher Scientific 的最新报告</strong></p>
<h2>Thermo Fisher Scientific 公司简介</h2>
<p>(免费报告)</p>
<p>Thermo Fisher Scientific Inc 在北美、欧洲、亚太地区及国际上提供生命科学解决方案、分析仪器、专业诊断、实验室产品和生物制药服务。该公司的生命科学解决方案部门为生物和医学研究、药物和疫苗的发现与生产，以及感染和疾病的诊断提供试剂、仪器和耗材；解决方案包括生物科学、遗传科学和生物生产，服务于制药、生物技术、农业、临床、医疗保健、学术和政府市场。</p>
<h2>进一步阅读</h2>
<ul>
<li>我们更看好的五只股票，而不是 Thermo Fisher Scientific</li>
<li>WallStreetBets 是什么，它们正在关注哪些股票？</li>
<li>你需要了解的突破性动量股票</li>
<li>顶级生物技术股票：探索创新机会</li>
<li>Quanta Services：AI 数据中心推动的支柱</li>
<li>ESG 股票，投资者应了解的事项</li>
<li>Archer 最近一系列胜利标志着增长的新阶段</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPVRNTw?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPVRNTw"/></p>
<p><em>此即时新闻提醒由叙述科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快和最准确的报道。此故事在发布前已由 MarketBeat 的编辑团队审核。如对该故事有任何问题或意见，请发送邮件至 contact@marketbeat.com。</em></p>
<h2>你现在应该投资 1,000 美元在 Thermo Fisher Scientific 吗？</h2>
<p>在考虑 Thermo Fisher Scientific 之前，你需要听听这个。</p>
<p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师悄悄建议客户现在购买的股票，以便在更广泛的市场注意到之前……而 Thermo Fisher Scientific 并不在名单上。</p>
<p>虽然 Thermo Fisher Scientific 目前在分析师中获得了适度买入评级，但顶级分析师认为这五只股票更值得购买。</p>
<p>在这里查看这五只股票</p>

赛默飞世尔

<p>Reliant Investment Management LLC 在第二季度将其在赛默飞世尔（Thermo Fisher Scientific Inc.，NYSE:TMO）的持股增加了 7.0%，额外购买了 860 股，总持股量达到 13,196 股，价值为 535 万美元。该股票占 Reliant 投资组合的 2.3%。其他机构投资者也增加了他们的持股。赛默飞世尔的股票开盘价为 568.42 美元，市值为 2146.4 亿美元。该公司报告了第三季度每股收益为 5.79 美元，超出预期，并将 2025 财年的指导目标设定在 22.600-22.860 美元每股收益</p>

<p>Reliant Investment Management LLC increased its stake in shares of Thermo Fisher Scientific Inc. (NYSE:TMO - Free Report) by 7.0% in the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 13,196 shares of the medical research company's stock after buying an additional 860 shares during the quarter. Thermo Fisher Scientific accounts for about 2.3% of Reliant Investment Management LLC's investment portfolio, making the stock its 25th largest position. Reliant Investment Management LLC's holdings in Thermo Fisher Scientific were worth $5,350,000 as of its most recent filing with the Securities and Exchange Commission (SEC).</p>
<div class="lb-trans"><p>Reliant Investment Management LLC 在最近向证券交易委员会（SEC）提交的 13F 文件中披露，其在赛默飞世尔（Thermo Fisher Scientific Inc.，NYSE:TMO - 免费报告）的股份在第二季度增加了 7.0%。该公司在本季度额外购买了 860 股后，持有该医疗研究公司 13,196 股股票。赛默飞世尔约占 Reliant Investment Management LLC 投资组合的 2.3%，成为其第 25 大持仓。根据其最近向证券交易委员会（SEC）提交的文件，Reliant Investment Management LLC 在赛默飞世尔的持股价值为 5,350,000 美元。</p>
</div><ul>
<li>Cash Flow Focus: Thermo Fisher, Energy Transfer, and NetEase</li>
</ul>
<div class="lb-trans"><ul>
<li>现金流关注：赛默飞世尔、能源转移和网易</li>
</ul>
</div><p>Several other hedge funds and other institutional investors have also modified their holdings of the stock. Revolve Wealth Partners LLC lifted its position in shares of Thermo Fisher Scientific by 4.2% during the 4th quarter. Revolve Wealth Partners LLC now owns 491 shares of the medical research company's stock worth $255,000 after buying an additional 20 shares during the period. Lafayette Investments Inc. lifted its position in shares of Thermo Fisher Scientific by 2.4% during the 2nd quarter. Lafayette Investments Inc. now owns 927 shares of the medical research company's stock worth $376,000 after buying an additional 22 shares during the period. Root Financial Partners LLC lifted its position in shares of Thermo Fisher Scientific by 5.0% during the 1st quarter. Root Financial Partners LLC now owns 506 shares of the medical research company's stock worth $252,000 after buying an additional 24 shares during the period. Rossmore Private Capital lifted its position in shares of Thermo Fisher Scientific by 0.5% during the 1st quarter. Rossmore Private Capital now owns 4,652 shares of the medical research company's stock worth $2,315,000 after buying an additional 24 shares during the period. Finally, FARMERS &amp; MERCHANTS TRUST Co OF LONG BEACH lifted its position in shares of Thermo Fisher Scientific by 3.1% during the 2nd quarter. FARMERS &amp; MERCHANTS TRUST Co OF LONG BEACH now owns 803 shares of the medical research company's stock worth $326,000 after buying an additional 24 shares during the period. Institutional investors own 89.23% of the company's stock.</p>
<div class="lb-trans"><p>其他几家对冲基金和机构投资者也调整了对该股票的持有。Revolve Wealth Partners LLC 在第四季度将其在赛默飞世尔的股份增加了 4.2%。Revolve Wealth Partners LLC 目前持有 491 股该医疗研究公司的股票，价值 255,000 美元，此前在该期间内额外购买了 20 股。Lafayette Investments Inc. 在第二季度将其在赛默飞世尔的股份增加了 2.4%。Lafayette Investments Inc. 目前持有 927 股该医疗研究公司的股票，价值 376,000 美元，此前在该期间内额外购买了 22 股。Root Financial Partners LLC 在第一季度将其在赛默飞世尔的股份增加了 5.0%。Root Financial Partners LLC 目前持有 506 股该医疗研究公司的股票，价值 252,000 美元，此前在该期间内额外购买了 24 股。Rossmore Private Capital 在第一季度将其在赛默飞世尔的股份增加了 0.5%。Rossmore Private Capital 目前持有 4,652 股该医疗研究公司的股票，价值 2,315,000 美元，此前在该期间内额外购买了 24 股。最后，FARMERS &amp; MERCHANTS TRUST Co OF LONG BEACH 在第二季度将其在赛默飞世尔的股份增加了 3.1%。FARMERS &amp; MERCHANTS TRUST Co OF LONG BEACH 目前持有 803 股该医疗研究公司的股票，价值 326,000 美元，此前在该期间内额外购买了 24 股。机构投资者持有该公司 89.23% 的股票。</p>
</div><h2>Thermo Fisher Scientific Stock Up 1.9%</h2>
<div class="lb-trans"><h2>赛默飞世尔股票上涨 1.9%</h2>
</div><p>NYSE:TMO opened at $568.42 on Thursday. Thermo Fisher Scientific Inc. has a 1 year low of $385.46 and a 1 year high of $610.97. The company has a current ratio of 1.93, a quick ratio of 1.50 and a debt-to-equity ratio of 0.65. The stock has a market cap of $214.64 billion, a price-to-earnings ratio of 32.88, a PEG ratio of 3.22 and a beta of 0.77. The stock has a 50-day moving average price of $500.65 and a two-hundred day moving average price of $451.30.</p>
<div class="lb-trans"><p>NYSE:TMO 周四开盘价为 568.42 美元。赛默飞世尔的 1 年最低价为 385.46 美元，1 年最高价为 610.97 美元。该公司的流动比率为 1.93，速动比率为 1.50，债务股本比率为 0.65。该股票的市值为 2146.4 亿美元，市盈率为 32.88，PEG 比率为 3.22，贝塔值为 0.77。该股票的 50 日移动平均价格为 500.65 美元，200 日移动平均价格为 451.30 美元。</p>
</div><ul>
<li>Agilent Technologies Thrives From the Forever Chemicals Crackdown</li>
</ul>
<div class="lb-trans"><ul>
<li>安捷伦科技受益于对持久化学品的打击</li>
</ul>
</div><p>Thermo Fisher Scientific (NYSE:TMO - Get Free Report) last issued its quarterly earnings results on Wednesday, October 22nd. The medical research company reported $5.79 EPS for the quarter, beating analysts' consensus estimates of $5.50 by $0.29. The company had revenue of $11.12 billion for the quarter, compared to analyst estimates of $10.90 billion. Thermo Fisher Scientific had a return on equity of 16.82% and a net margin of 15.24%.The company's quarterly revenue was up 4.9% compared to the same quarter last year. During the same period in the previous year, the company posted $5.28 earnings per share. Thermo Fisher Scientific has set its FY 2025 guidance at 22.600-22.860 EPS. As a group, equities analysts expect that Thermo Fisher Scientific Inc. will post 23.28 earnings per share for the current year.</p>
<div class="lb-trans"><p>赛默飞世尔（NYSE:TMO - 获取免费报告）最近于 10 月 22 日发布了季度财报。该医疗研究公司报告本季度每股收益为 5.79 美元，超出分析师一致预期的 5.50 美元，超出幅度为 0.29 美元。该公司本季度的收入为 111.2 亿美元，而分析师预期为 109 亿美元。赛默飞世尔的股本回报率为 16.82%，净利润率为 15.24%。与去年同期相比，该公司的季度收入增长了 4.9%。在去年同期，该公司每股收益为 5.28 美元。赛默飞世尔已将其 2025 财年的指引设定为每股收益 22.600-22.860 美元。整体来看，股票分析师预计赛默飞世尔在当前年度将发布每股收益 23.28 美元。</p>
</div><h2>Insider Buying and Selling at Thermo Fisher Scientific</h2>
<div class="lb-trans"><h2>赛默飞世尔的内部买卖</h2>
</div><p>In other Thermo Fisher Scientific news, EVP Gianluca Pettiti sold 400 shares of Thermo Fisher Scientific stock in a transaction on Friday, July 25th. The stock was sold at an average price of $479.98, for a total value of $191,992.00. Following the completion of the transaction, the executive vice president directly owned 22,367 shares of the company's stock, valued at $10,735,712.66. The trade was a 1.76% decrease in their position. The sale was disclosed in a legal filing with the Securities &amp; Exchange Commission, which is available at the SEC website. Also, CAO Joseph R. Holmes sold 385 shares of the company's stock in a transaction on Friday, August 29th. The stock was sold at an average price of $492.63, for a total value of $189,662.55. Following the sale, the chief accounting officer owned 2,319 shares of the company's stock, valued at $1,142,408.97. The trade was a 14.24% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 30,066 shares of company stock worth $14,182,963 over the last 90 days. Company insiders own 0.33% of the company's stock.</p>
<div class="lb-trans"><p>在其他赛默飞世尔的新闻中，执行副总裁 Gianluca Pettiti 于 7 月 25 日星期五出售了 400 股赛默飞世尔的股票。该股票以平均价格 479.98 美元出售，总价值为 191,992.00 美元。交易完成后，该执行副总裁直接持有 22,367 股公司的股票，价值 10,735,712.66 美元。此次交易使其持股减少了 1.76%。该出售在向证券交易委员会的法律文件中披露，相关信息可在 SEC 网站上找到。此外，首席会计官 Joseph R. Holmes 于 8 月 29 日星期五出售了 385 股公司的股票。该股票以平均价格 492.63 美元出售，总价值为 189,662.55 美元。出售后，首席会计官持有 2,319 股公司的股票，价值 1,142,408.97 美元。此次交易使其持股减少了 14.24%。该出售的披露信息可在此处找到。在过去 90 天内，内部人士已出售价值 14,182,963 美元的 30,066 股公司股票。公司内部人士持有公司股票的 0.33%。</p>
</div><h2>Analysts Set New Price Targets</h2>
<div class="lb-trans"><h2>分析师设定新的价格目标</h2>
</div><ul>
<li>Top 4 Fastest Growing S&amp;P 500 Dividends: Buy, Sell, or Hold?</li>
</ul>
<div class="lb-trans"><ul>
<li>S&amp;P 500 中增长最快的 4 大股息：买入、卖出还是持有？</li>
</ul>
</div><p>Several brokerages have issued reports on TMO. JPMorgan Chase &amp; Co. lifted their price objective on Thermo Fisher Scientific from $600.00 to $650.00 and gave the company an &#34;overweight&#34; rating in a research report on Thursday, October 9th. Royal Bank Of Canada set a $561.00 price objective on Thermo Fisher Scientific and gave the company an &#34;outperform&#34; rating in a research report on Tuesday, September 2nd. Robert W. Baird lifted their price objective on Thermo Fisher Scientific from $553.00 to $567.00 and gave the company an &#34;outperform&#34; rating in a research report on Thursday, July 24th. Barclays lifted their price objective on Thermo Fisher Scientific from $550.00 to $585.00 and gave the company an &#34;overweight&#34; rating in a research report on Thursday, October 2nd. Finally, Raymond James Financial reiterated an &#34;outperform&#34; rating and issued a $535.00 price objective (up previously from $525.00) on shares of Thermo Fisher Scientific in a research report on Thursday, July 24th. Sixteen research analysts have rated the stock with a Buy rating and five have issued a Hold rating to the company's stock. According to data from MarketBeat.com, the stock presently has a consensus rating of &#34;Moderate Buy&#34; and a consensus target price of $582.16.</p>
<div class="lb-trans"><p>多家券商对 Thermo Fisher Scientific 发布了报告。摩根大通将 Thermo Fisher Scientific 的目标价从 600.00 美元上调至 650.00 美元，并在 10 月 9 日的研究报告中给予该公司 “增持” 评级。加拿大皇家银行在 9 月 2 日的研究报告中设定了 Thermo Fisher Scientific 的目标价为 561.00 美元，并给予该公司 “跑赢大盘” 评级。罗伯特·W·贝尔德将 Thermo Fisher Scientific 的目标价从 553.00 美元上调至 567.00 美元，并在 7 月 24 日的研究报告中给予该公司 “跑赢大盘” 评级。巴克莱将 Thermo Fisher Scientific 的目标价从 550.00 美元上调至 585.00 美元，并在 10 月 2 日的研究报告中给予该公司 “增持” 评级。最后，雷蒙德·詹姆斯金融在 7 月 24 日的研究报告中重申了 “跑赢大盘” 评级，并将 Thermo Fisher Scientific 的目标价设定为 535.00 美元（之前为 525.00 美元）。十六位研究分析师对该股票给予了买入评级，五位分析师对该公司的股票给予了持有评级。根据 MarketBeat.com 的数据，该股票目前的共识评级为 “适度买入”，共识目标价为 582.16 美元。</p>
</div><p><strong>Get Our Latest Report on Thermo Fisher Scientific</strong></p>
<div class="lb-trans"><p><strong>获取我们关于 Thermo Fisher Scientific 的最新报告</strong></p>
</div><h2>Thermo Fisher Scientific Company Profile</h2>
<div class="lb-trans"><h2>Thermo Fisher Scientific 公司简介</h2>
</div><p>(Free Report)</p>
<div class="lb-trans"><p>(免费报告)</p>
</div><p>Thermo Fisher Scientific Inc provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases; and solutions include biosciences, genetic sciences, and bio production to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets.</p>
<div class="lb-trans"><p>Thermo Fisher Scientific Inc 在北美、欧洲、亚太地区及国际上提供生命科学解决方案、分析仪器、专业诊断、实验室产品和生物制药服务。该公司的生命科学解决方案部门为生物和医学研究、药物和疫苗的发现与生产，以及感染和疾病的诊断提供试剂、仪器和耗材；解决方案包括生物科学、遗传科学和生物生产，服务于制药、生物技术、农业、临床、医疗保健、学术和政府市场。</p>
</div><h2>Further Reading</h2>
<div class="lb-trans"><h2>进一步阅读</h2>
</div><ul>
<li>Five stocks we like better than Thermo Fisher Scientific</li>
<li>What Is WallStreetBets and What Stocks Are They Targeting?</li>
<li>Breakout Momentum Plays You Need to Know About</li>
<li>Top Biotech Stocks: Exploring Innovation Opportunities</li>
<li>Quanta Services: The Backbone of the AI Data Center Push</li>
<li>ESG Stocks, What Investors Should Know</li>
<li>Archer’s Recent String of Victories Signals a New Phase of Growth</li>
</ul>
<div class="lb-trans"><ul>
<li>我们更看好的五只股票，而不是 Thermo Fisher Scientific</li>
<li>WallStreetBets 是什么，它们正在关注哪些股票？</li>
<li>你需要了解的突破性动量股票</li>
<li>顶级生物技术股票：探索创新机会</li>
<li>Quanta Services：AI 数据中心推动的支柱</li>
<li>ESG 股票，投资者应了解的事项</li>
<li>Archer 最近一系列胜利标志着增长的新阶段</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPVRNTw" alt="" original-src="https://www.marketbeat.com/scripts/SECFilingChart.ashx?Prefix=NYSE&amp;Symbol=TMO"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即时新闻提醒由叙述科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快和最准确的报道。此故事在发布前已由 MarketBeat 的编辑团队审核。如对该故事有任何问题或意见，请发送邮件至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in Thermo Fisher Scientific Right Now?</h2>
<div class="lb-trans"><h2>你现在应该投资 1,000 美元在 Thermo Fisher Scientific 吗？</h2>
</div><p>Before you consider Thermo Fisher Scientific, you'll want to hear this.</p>
<div class="lb-trans"><p>在考虑 Thermo Fisher Scientific 之前，你需要听听这个。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Thermo Fisher Scientific wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师悄悄建议客户现在购买的股票，以便在更广泛的市场注意到之前……而 Thermo Fisher Scientific 并不在名单上。</p>
</div><p>While Thermo Fisher Scientific currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>虽然 Thermo Fisher Scientific 目前在分析师中获得了适度买入评级，但顶级分析师认为这五只股票更值得购买。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在这里查看这五只股票</p>
</div>

Reliant Investment Management LLC 购买了 860 股赛默飞世尔公司的股票$TMO